Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2005
08/23/2005US6933113 Modulation of endogenous gene expression in cells
08/23/2005US6932960 Complexes with radionuclides; for use as contrast agent in magnetic resonance imaging (MRI); as parasiticide, viricide, or as chelation therapy of iron overload such as thalassemia; optimal combination of lipophilicity and hydrophilicity
08/23/2005CA2350956C New crystals of celecoxib
08/23/2005CA2267661C Variants of vascular endothelial cell growth factor having antagonistic properties
08/23/2005CA2266884C Inhibition of 26s and 20s proteasome by indanones
08/23/2005CA2094276C Antibodies against the urokinase receptor and their use
08/23/2005CA2070281C Improved treatment of autoimmune diseases by aerosol administration of auto antigens
08/19/2005WO2004069263A1 Analgesic composition
08/19/2005CA2513932A1 Analgesic composition
08/18/2005WO2005075414A1 Peptidyl arginine deiminase type iv inhibitor
08/18/2005WO2005074907A1 Gene expression controlling agent
08/18/2005WO2005035003A3 Compositions and methods for increasing drug efficiency
08/18/2005WO2003004608A3 Drug metabolizing enzymes
08/18/2005US20050182244 Modified polypeptides stabilized in a desired conformation and methods for producing same
08/18/2005US20050182130 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
08/18/2005US20050182126 2-Thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/18/2005US20050182103 Substituted 2,3-diphenyl pyridines
08/18/2005US20050182094 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens
08/18/2005US20050182093 Novel compounds
08/18/2005US20050182070 Method for the treatment of allergic conditions
08/18/2005US20050182069 For treatment of asthma, allergies, inflammation and anxiety; antihistamines; sedatives; tranquilizing agents; 2[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetamide
08/18/2005US20050182057 Aryl N-cyanoguanidines and methods related thereto
08/18/2005US20050182054 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
08/18/2005US20050182040 Benzamide derivatives
08/18/2005US20050182035 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease, cancer, skin disorders, immune system disorders, asthma, hypertension, hypothyroidism, hypocalcemia, female infertility and alopecia
08/18/2005US20050182034 Method of locking 1alpha-OH of vitamin D compounds in axial orientation
08/18/2005US20050182000 Anti-inflammatory compounds derived from Pseudopterogorgia elisabethae
08/18/2005US20050181995 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof
08/18/2005US20050181501 Anti-TECK antibodies and methods of use therefor
08/18/2005US20050181457 Mixture comprising immunogllobulin G complex for diagnosis, prevention and treatment of autoimmune and allergic disorders
08/18/2005US20050181448 Biological products
08/18/2005US20050181414 Peptides associated with serine protease active site for use in identification of modulators for treatment of cell proliferative disorders
08/18/2005US20050181066 Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency
08/18/2005US20050181038 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
08/18/2005US20050180973 TREM-1 splice variant for use in modifying immune responses
08/18/2005US20050180926 Inhalable aerosol medicament for the treatment or prevention of pain
08/18/2005DE102004004787A1 New effector-linker and effector-recognition unit conjugates derived from epothilones, useful as targeted drugs for treating proliferative diseases, e.g. tumors or neurodegenerative disease
08/18/2005CA2555491A1 Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof
08/18/2005CA2555199A1 Peptidylarginine deiminase 4 inhibitor
08/18/2005CA2554705A1 Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases
08/18/2005CA2554626A1 Silinane compounds as cysteine protease inhibitors
08/17/2005EP1563858A1 Peritoneal dialysis method
08/17/2005EP1563845A1 Remedies for allergic diseases
08/17/2005EP1563843A1 Botulinum toxins for treating various disorders and associated pain
08/17/2005EP1563839A1 A method of analgesia
08/17/2005EP1563083A2 Use of cytokines secreted by dendritic cells
08/17/2005EP1562967A2 Adipocyte complement related protein zacrp14
08/17/2005EP1562958A1 N-sulfonylaminothiazole
08/17/2005EP1562940A2 Aryl sulfonamides
08/17/2005EP1562936A2 Therapeutic piperazine compounds
08/17/2005EP1562934A1 Amino-heterocycles as vr-1 antagonists for treating pain
08/17/2005EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders
08/17/2005EP1562920A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
08/17/2005EP1562910A1 Celecoxib prodrug
08/17/2005EP1562907A1 Pyridine derivatives as cb2 receptor modulators
08/17/2005EP1562902A1 2-pyridone derivatives as inhibitors of neutrophile elastase
08/17/2005EP1562625A2 Pain relief agents
08/17/2005EP1562579A1 Therapeutic delivery of carbon monoxide
08/17/2005EP1562567A1 Combination of selected analgesics and cox-ii inhibitors
08/17/2005EP1562566A1 Analgesic compositions comprising nmda receptor antagonists and benzalkonium chloride
08/17/2005EP1377558B1 [1,4]-diazepane-1-carboxylic acid derivatives, process for their preparation and their use as tachykinin antagonists
08/17/2005EP1315496B1 The treatment of inflammatory disorders
08/17/2005EP1196397B1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
08/17/2005EP1161240B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
08/17/2005EP1144385B1 Benzoheterocycles and their use as mek inhibitors
08/17/2005EP1087943B1 Therapeutic biaryl derivatives
08/17/2005EP1023445B1 Cadherin derived growth factor and the application thereof
08/17/2005EP0989982B1 Barbituric acid derivatives with antimetastatic and antitumor activity
08/17/2005EP0939804B1 NEUTROKINE alpha
08/17/2005EP0938305B1 Method of alleviating pain by means of combining tramadol with an nmda antagonist
08/17/2005EP0835128B1 Use of il-11 to treat inflammation
08/17/2005CN1656113A Sialic combined immunoglobulin like agglutinin inhibitors
08/17/2005CN1656102A Fused bicyclic pyridine derivative as tachykinin receptor antagonist
08/17/2005CN1656099A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
08/17/2005CN1656098A Fused bicyclic pyrimidine derivatives
08/17/2005CN1656095A Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
08/17/2005CN1656094A 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders
08/17/2005CN1656093A 3-substituted quinuclidines and their use
08/17/2005CN1656092A Robertson Graeme Michael et al.
08/17/2005CN1656090A Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
08/17/2005CN1656089A Phenyl-thiophene type vitamin D receptor modulators
08/17/2005CN1656087A Therapeutic ion channel blocking agents and methods of use thereof
08/17/2005CN1656085A Carboxylic acid compounds and drugs containing the compounds as the active ingredient
08/17/2005CN1656082A Protein kinase inhibitors
08/17/2005CN1656079A Pyrazole compounds and pharmaceutical compositions comprising the compound
08/17/2005CN1656073A Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
08/17/2005CN1656072A Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
08/17/2005CN1656070A Melanocortin receptor ligands
08/17/2005CN1656067A New salts
08/17/2005CN1656057A N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
08/17/2005CN1655823A Topically applicable pharmaceutical preparation
08/17/2005CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
08/17/2005CN1655809A Compositions and methods for treating and preventing necrosis
08/17/2005CN1655799A Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
08/17/2005CN1655787A Triple monoamine reuptake inhibitors for the treatment of chronic pain
08/17/2005CN1655785A N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
08/17/2005CN1655783A Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
08/17/2005CN1655782A Ophthalmological use of roflumilast for the treatment of diseases of the eye
08/17/2005CN1655774A Bis-aromatic alkanols
08/17/2005CN1655770A Chewable soft capsule
1 ... 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 ... 1272